Hostname: page-component-6898cfcb55-cbk24 Total loading time: 0 Render date: 2026-11-11T14:42:11.610Z Has data issue: false hasContentIssue false

Pilot implementation of the GAIHN point prevalence survey on healthcare-associated infections at a Jordanian tertiary oncology hospital, an international partnership with the U.S. Centers for Disease Control and Prevention

Published online by Cambridge University Press:  23 September 2026

Sawsan Mubarak
Affiliation:
King Hussein Cancer Center , Jordan
Joud Jarrah
Affiliation:
King Hussein Cancer Center , Jordan
Manar Makhlouf
Affiliation:
King Hussein Cancer Center , Jordan
Rawan Hajir
Affiliation:
King Hussein Cancer Center , Jordan
Sulafa Al Ansari
Affiliation:
King Hussein Cancer Center , Jordan
Hebah Beides
Affiliation:
King Hussein Cancer Center , Jordan
Hadeel AlGhawrie*
Affiliation:
King Hussein Cancer Center , Jordan
*
Corresponding author: Hadeel AlGhawrie; Email: ha.15907@khcc.jo

Abstract

Background:

The Global Action in Healthcare Network develops point prevalence survey (PPS) protocol for healthcare-associated infection surveillance, particularly in resource-limited settings. This study reports the first field implementation of the Global Action in Healthcare Network (GAIHN) HAI PPS protocol and aims to evaluate the protocol and to estimate healthcare-associated infection (HAI) prevalence and antimicrobial use at a tertiary oncology hospital in Jordan.

Methods:

Descriptive, cross-sectional point prevalence survey conducted using a standardized GAIHN HAI PPS protocol, coordinated by the U.S. Centers for Disease Control and Prevention, was implemented using an algorithmic REDCap-based data collection system. Targeted HAIs included bloodstream infection, pneumonia, urinary tract infection, and surgical site infection. Antimicrobial use, device exposure, microbiology, and ward-level characteristics were recorded. HAI prevalence was calculated with 95% confidence intervals.

Results:

A total of 124 patients were surveyed, 73 (58.9%) underwent full chart review. Antimicrobial use was documented in 63.7% of surveyed patients, with an Access-to-Watch ratio of 0.23. Eight HAI events were identified in six patients, corresponding to an overall HAI prevalence of 4.8% (6/124; 95% CI 2.2–10.1). Pneumonia was the most frequent HAI type. Gram-negative organisms accounted for 60% of isolates. Patients in intensive care was more likely to meet criteria for detailed review.

Conclusion:

This pilot demonstrated feasibility for the GAIHN HAI PPS methodology and data collection system. It offers a framework for improving IPC programs and implementing evidence-based practices that can be adapted and scaled across the region, contributing to the global effort to reduce HAIs and combat antimicrobial resistance.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Patient demographics and clinical information by indication for full chart review—KHCC HAI PPSTable 1 long description.

Figure 1

Table 2.Summary of prescribed antimicrobials by WHO anatomical therapeutic chemical classification—KHCC HAI PPSTable 2 long description.

Figure 2

Table 3.List of eight infections classified as healthcare-associated by patient, presence of a relevant device, and ward surveyed—KHCC HAI PPSTable 3 long description.

Supplementary material: File

Mubarak et al. supplementary material 1

Mubarak et al. supplementary material
Download Mubarak et al. supplementary material 1(File)
File 18.6 KB
Supplementary material: File

Mubarak et al. supplementary material 2

Mubarak et al. supplementary material
Download Mubarak et al. supplementary material 2(File)
File 117.8 KB
Supplementary material: File

Mubarak et al. supplementary material 3

Mubarak et al. supplementary material
Download Mubarak et al. supplementary material 3(File)
File 56.7 KB
Supplementary material: File

Mubarak et al. supplementary material 4

Mubarak et al. supplementary material
Download Mubarak et al. supplementary material 4(File)
File 56.1 KB